Wikia

Psychology Wiki

MMDA (psychedelic)

Talk0
34,140pages on
this wiki
Revision as of 07:27, June 7, 2007 by Dr Joe Kiff (Talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Assessment | Biopsychology | Comparative | Cognitive | Developmental | Language | Individual differences | Personality | Philosophy | Social |
Methods | Statistics | Clinical | Educational | Industrial | Professional items | World psychology |

Biological: Behavioural genetics · Evolutionary psychology · Neuroanatomy · Neurochemistry · Neuroendocrinology · Neuroscience · Psychoneuroimmunology · Physiological Psychology · Psychopharmacology (Index, Outline)


MMDA
Chemical name 3-methoxy-4,5-Methylenedioxyamphetamine
or
1-(7-methoxy-1,3-benzodioxol-5-yl)propan-2-amine
Chemical formula C11H15NO3
Molecular mass 209.2417 g/mol
Melting point 133-134 °C (hydrochloride)
CAS numbers 13674-05-0
SMILES CC(N)Cc1cc2OCOc2c(c1)OC
MMDA

MMDA, or 3-methoxy-4,5-methylenedioxyamphetamine, is a stimulant, a psychedelic drug, an entheogen, and an entactogen. It is a substituted Amphetamine and an analogue of MDA, Lophophine and MDMA (Ecstasy). It bears resemblance to the psychopharmacologically active essential oils elemicin and myristicin found in nutmeg. MMDA is most typically taken orally (as pressed tablets) or intranasaly (as a powder).

MMDA was written up by Alexander Shulgin in his book, "PiHKAL." Shulgin lists the dosage range of MMDA as 100-250 mg. The first symptoms appear within 30-60 minutes following oral administration. MMDA causes accentuation of feelings such as anxiety, euphoria, loneliness, and loving warmth. MMDA also produces eyes-closed visuals, a state of drowsiness and muscular relaxation, and time distortion. Side effects include moderate mydriasis, dizziness, sensations of heat or cold, and trembling. The imagery is generally realistic, and often related to everyday perception of people, landscapes, or objects. The effects of MMDA usually reach a peak after the first hour following the initial symptoms, and begin to wane during the second hour, and usually completely disappear by the end of the fifth hour.

Homologues Edit

MMDA-2

MMDA-2, or 2-methoxy-4,5-methylenedioxyamphetamine

Methyl-MMDA-2

Methyl-MMDA-2, or 2-methoxy-4,5-methylenedioxymethamphetamine

MMDA-3a

MMDA-3a or 2-methoxy-3,4-methylenedioxyamphetamine

MMDA-3b

MMDA-3b or 4-methoxy-2,3-methylenedioxyamphetamine

2T-MMDA-3a

2T-MMDA-3a or 2-methylthio-3,4-methylenethioxyamphetamine

4T-MMDA-2

4T-MMDA-2 or 2-methoxy-4,5-methylenethioxyamphetamine

MMDA-2Edit

Dosage: 25-50 mgs

Duration: 8-12 hours

Effects: slow, MDA-like effects, muscle stiffness, inability to defecate

Methyl-MMDA-2Edit

Dosage: unknown

Duration: unknown

Effects: Few to none

MMDA-3aEdit

Dosage: 20-80 mgs

Duration: 10-16 hours

Effects: mild open-eye visuals, visual enhancement of music, slowing of time, slight diarhea and body load

MMDA-3bEdit

Dosage: unknown

Duration: unknown

Effects: Few to none

2T-MMDA-3aEdit

Dosage: unknown

Duration: unknown

Effects: Few to none

4T-MMDA-2Edit

Dosage: 25 mg

Duration: unknown

Effects: Slight tremors

Psychotherapuetic actionsEdit

In his 1973 book, "The Healing Journey," Claudio Naranjo explored the psychotherapeutic potential of MMDA. Like MDA, he found that MMDA facilitates communication and suggested it has potential applications in psychotherapy. Worldwide as of 2005, MMDA has not been approved for any human applications.

PharmacologyEdit

The mechanism that produces the psychedelic activity of MMDA has not been definitively established. There are, as of the present time, no reported studies on the human pharmacokinetics or metabolism of MMDA. Based on its structural relationship with other similar drugs for which the pharmacology is known, it is likely that MMDA has multiple mechanisms of action, and probably acts both as a 5HT2A agonist in a similar manner to hallucinogenic amphetamines such as DOM, and also as a serotonin releaser by reversing the direction of the serotonin reuptake transporter in a similar manner to MDMA.

LegalityEdit

MMDA is classified as a Schedule 1 substance in the United States, and is similarly controlled in other parts of the world. Internationally, MMDA is a Schedule I drug under the Convention on Psychotropic Substances[1].

See alsoEdit

External linksEdit




.

This page uses Creative Commons Licensed content from Wikipedia (view authors).

Around Wikia's network

Random Wiki